INTENSITY THERAPEUTICS, INC.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Emerging growth company
State of Incorporation
DE
Business Address
1 ENTERPRISE DRIVE, SUITE 430, SHELTON, CT, 06484
Mailing Address
1 ENTERPRISE DRIVE, SUITE 430, SHELTON, CT, 06484
Phone
203-221-7381
Fiscal Year End
1231
EIN
461488089
Financial Overview
FY2025
$14.10M
Total Assets
$11.92M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | March 30, 2026 | View on SEC |
| 10-K Annual financial report | March 27, 2026 | View on SEC |
| 8-K Current report of material events | March 27, 2026 | View on SEC |
| 8-K Current report of material events | March 23, 2026 | View on SEC |
| 424B5 Prospectus supplement | March 23, 2026 | View on SEC |
| 8-K Current report of material events | March 6, 2026 | View on SEC |
| 8-K Current report of material events | March 5, 2026 | View on SEC |
| 8-K Current report of material events | February 13, 2026 | View on SEC |
| 4 Insider stock transaction report | January 5, 2026 | View on SEC |
| 4 Insider stock transaction report | January 5, 2026 | View on SEC |
Annual Reports
10-K
March 27, 2026
- Validated commercial-scale manufacturing process for INT230-6
- Reached formal agreement with the FDA on Phase 3 trial goals
Material Events
8-K
Financial Distress
February 13, 2026
High Impact
- Regaining Nasdaq compliance to avoid delisting.
- Improving marketability and attracting institutional investors.
8-K
Financial Distress
December 5, 2025
High Impact
- INTENSITY THERAPEUTICS, INC. received an extension from Nasdaq to regain compliance with the minimum bid price requirement.
- The company's stock price has been trading below $1.00 per share, violating Nasdaq's listing rules.
Related Companies
Companies in the same industry (SIC: 2836)
NEUROCRINE BIOSCIENCES INC
NBIX
Biological Products, (No Diagnostic Substances)
Vor Biopharma Inc.
VOR
Biological Products, (No Diagnostic Substances)
Replimune Group, Inc.
REPL
Biological Products, (No Diagnostic Substances)
BioAtla, Inc.
BCAB
Biological Products, (No Diagnostic Substances)
Vericel Corp
VCEL
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.